473 related articles for article (PubMed ID: 17689528)
1. Cysteinyl leukotriene receptor antagonist MK-571 alters bronchoalveolar lavage fluid proteome in a mouse asthma model.
Wong WS; Zhu H; Liao W
Eur J Pharmacol; 2007 Dec; 575(1-3):134-41. PubMed ID: 17689528
[TBL] [Abstract][Full Text] [Related]
2. Involvement of LTD(4)in allergic pulmonary inflammation in mice: modulation by cysLT(1)antagonist MK-571.
Blain JF; Sirois P
Prostaglandins Leukot Essent Fatty Acids; 2000 Jun; 62(6):361-8. PubMed ID: 10913229
[TBL] [Abstract][Full Text] [Related]
3. Dexamethasone alters bronchoalveolar lavage fluid proteome in a mouse asthma model.
Zhao J; Yeong LH; Wong WS
Int Arch Allergy Immunol; 2007; 142(3):219-29. PubMed ID: 17108703
[TBL] [Abstract][Full Text] [Related]
4. Comparison study between the mechanisms of allergic asthma amelioration by a cysteinyl-leukotriene type 1 receptor antagonist montelukast and methylprednisolone.
Murai A; Abe M; Hayashi Y; Sakata N; Katsuragi T; Tanaka K
J Pharmacol Exp Ther; 2005 Feb; 312(2):432-40. PubMed ID: 15470084
[TBL] [Abstract][Full Text] [Related]
5. Proteome analysis of chronically inflamed lungs in a mouse chronic asthma model.
Wong WS; Zhao J
Int Arch Allergy Immunol; 2008; 147(3):179-89. PubMed ID: 18594147
[TBL] [Abstract][Full Text] [Related]
6. Role of cysteinyl leukotrienes in airway inflammation and responsiveness following RSV infection in BALB/c mice.
Fullmer JJ; Khan AM; Elidemir O; Chiappetta C; Stark JM; Colasurdo GN
Pediatr Allergy Immunol; 2005 Nov; 16(7):593-601. PubMed ID: 16238585
[TBL] [Abstract][Full Text] [Related]
7. The effects of low dose leukotriene receptor antagonist therapy on airway remodeling and cysteinyl leukotriene expression in a mouse asthma model.
Muz MH; Deveci F; Bulut Y; Ilhan N; Yekeler H; Turgut T
Exp Mol Med; 2006 Apr; 38(2):109-18. PubMed ID: 16672764
[TBL] [Abstract][Full Text] [Related]
8. Comparative study to elucidate the mechanism underlying the difference in airway hyperresponsiveness between two mouse strains.
Fukunaga J; Abe M; Murai A; Akitake Y; Hosokawa M; Takahashi M
Int Immunopharmacol; 2007 Dec; 7(14):1852-61. PubMed ID: 18039522
[TBL] [Abstract][Full Text] [Related]
9. Effects of a cysteinyl leukotriene dual 1/2 receptor antagonist on antigen-induced airway hypersensitivity and airway inflammation in a guinea pig asthma model.
Muraki M; Imbe S; Santo H; Sato R; Sano H; Iwanaga T; Tohda Y
Int Arch Allergy Immunol; 2011; 155 Suppl 1():90-5. PubMed ID: 21646802
[TBL] [Abstract][Full Text] [Related]
10. Increased lungkine and chitinase levels in allergic airway inflammation: a proteomics approach.
Zhao J; Zhu H; Wong CH; Leung KY; Wong WS
Proteomics; 2005 Jul; 5(11):2799-807. PubMed ID: 15996009
[TBL] [Abstract][Full Text] [Related]
11. Anti-inflammatory mechanism of simvastatin in mouse allergic asthma model.
Kim DY; Ryu SY; Lim JE; Lee YS; Ro JY
Eur J Pharmacol; 2007 Feb; 557(1):76-86. PubMed ID: 17169357
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of Duchesnea chrysantha extract on ovalbumin-induced lung inflammation in a mouse model of asthma.
Yang EJ; Lee JS; Yun CY; Kim JH; Kim JS; Kim DH; Kim IS
J Ethnopharmacol; 2008 Jun; 118(1):102-7. PubMed ID: 18485641
[TBL] [Abstract][Full Text] [Related]
13. Effect of selective cysteinyl leukotriene receptor antagonists on airway inflammation and matrix metalloproteinase expression in a mouse asthma model.
Hsu CH; Hu CM; Lu KH; Yang SF; Tsai CH; Ko CL; Sun HL; Lue KH
Pediatr Neonatol; 2012 Aug; 53(4):235-44. PubMed ID: 22964281
[TBL] [Abstract][Full Text] [Related]
14. [The effect of montelukast on airway remodeling and the expression of interleukins and transforming growth factor-beta2 mRNA].
Bai JW; Deng WW; Wu HC
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Aug; 27(8):524-8. PubMed ID: 15388000
[TBL] [Abstract][Full Text] [Related]
15. Effect of a cysteinyl leukotriene receptor antagonist on experimental emphysema and asthma combined with emphysema.
Ikeda G; Miyahara N; Koga H; Fuchimoto Y; Waseda K; Kurimoto E; Taniguchi A; Tanimoto Y; Kataoka M; Tanimoto M; Kanehiro A
Am J Respir Cell Mol Biol; 2014 Jan; 50(1):18-29. PubMed ID: 23937413
[TBL] [Abstract][Full Text] [Related]
16. A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model.
Henderson WR; Tang LO; Chu SJ; Tsao SM; Chiang GK; Jones F; Jonas M; Pae C; Wang H; Chi EY
Am J Respir Crit Care Med; 2002 Jan; 165(1):108-16. PubMed ID: 11779739
[TBL] [Abstract][Full Text] [Related]
17. Reversal of allergen-induced airway remodeling by CysLT1 receptor blockade.
Henderson WR; Chiang GK; Tien YT; Chi EY
Am J Respir Crit Care Med; 2006 Apr; 173(7):718-28. PubMed ID: 16387808
[TBL] [Abstract][Full Text] [Related]
18. Blockade of cysteinyl leukotriene-1 receptors suppresses airway remodelling in mice overexpressing GATA-3.
Kiwamoto T; Ishii Y; Morishima Y; Yoh K; Kikuchi N; Haraguchi N; Masuko H; Kawaguchi M; Nomura A; Sakamoto T; Takahashi S; Hizawa N
Clin Exp Allergy; 2011 Jan; 41(1):116-28. PubMed ID: 20636401
[TBL] [Abstract][Full Text] [Related]
19. Montelukast modulates lung CysLT(1) receptor expression and eosinophilic inflammation in asthmatic mice.
Zhang YJ; Zhang L; Wang SB; Shen HH; Wei EQ
Acta Pharmacol Sin; 2004 Oct; 25(10):1341-6. PubMed ID: 15456537
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of synthetic somatostatin receptor subtype 4 agonists on acute and chronic airway inflammation and hyperreactivity in the mouse.
Elekes K; Helyes Z; Kereskai L; Sándor K; Pintér E; Pozsgai G; Tékus V; Bánvölgyi A; Németh J; Szuts T; Kéri G; Szolcsányi J
Eur J Pharmacol; 2008 Jan; 578(2-3):313-22. PubMed ID: 17961545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
